6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
6m ago	Sun Pharma signs Definitive Agreement to Acquire Organon
3h ago	Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
4h ago	NOBLE CORPORATION PLC ANNOUNCES FIRST QUARTER 2026 RESULTS
6h ago	Data at Heart Rhythm 2026 highlight key Boston Scientific therapies
7h ago	Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026

About

Sarepta Therapeutics Inc (NASDAQ:SRPT) — investor relations, events, news, and company updates on 6ix.

Latest News

Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®

Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne

Sarepta Therapeutics Announces Call for Applications for the 9th Annual Route 79, The Duchenne Scholarship Program

Financials

Revenue

$2.2 B

Market Cap

$2.44 B

EPS

-7.13

Community Chat

Ask AI